We next assessed the modulation of this cytokine profile in each patient before and after infliximab therapy (acute disease versus remission), observing a strong reduction in several cytokines, whilst changes in transcript levels of IL33 or IL1RL1 did not reach statistical significance ( Fig. 1b ).
← all excerpts
Loss of interleukin 33 expression in colonic crypts - a potential marker for disease remission in ulcerative colitis.
1
—
—